(Q33370110)
Statements
A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer (English)
G D'Agostino
J del Campo
B Mellado
M A Izquierdo
T Minarik
L Cirri
L Marini
scientific article